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Alzheimer’s Disease (AD) is the most common form of senile dementia and 
affects millions of people worldwide.  Patients with AD suffer from progressive memory 
loss that is caused by the loss of neurons and synapses in the portions of the brain 
responsible for memory and cognitive ability.1  AD is characterized by the formation of 
senile plaques made mostly of the Amyloid Beta peptide and neurofibrillary tangles 
consisting of the Tau protein.  The onset of AD seems to be correlated with changes in 
the concentrations of the Amyloid Beta peptides and the Tau protein.2  The relative 
concentrations of Aβ42 to Aβ40 and the total amount of Tau can be used as biomarkers for 
the early detection of AD.3  A fast, multianalyte analysis of these biomarkers could 
provide useful information in the diagnosis of the disease as well as a means of tracking 
disease progression.  Capillary electrophoresis is a fast separations technique that allows 
for the separation of analyte based on the size to charge ratio.  This technique coupled 
with laser-induced fluorescence is capable of picomolar limits of detection.  This study 
focuses on a novel functionalized gold nanoparticle enhanced capillary electrophoresis 
technique for the separation and quantitation these Alzheimer’s Disease biomarkers.
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MS ------------------------------------------------ mass spectrometer 
NFT ----------------------------------------------- neurofibrillary tangle 
NMR ---------------------------------------------- nuclear magnetic resonance 
pTau----------------------------------------------- phosphorylated tau protein 
SAM ---------------------------------------------- self assembled monolayer 
SDS ----------------------------------------------- sodium dodecyl sulfate 
SPR ----------------------------------------------- surface plasmon resonance 
TIC ------------------------------------------------ total ion chromatogram 
THF ----------------------------------------------- tetrahydrofuran 
TOF ----------------------------------------------- time of flight 
tTau ----------------------------------------------- total amount of tau protein 
UV-Vis ------------------------------------------- ultra violet-visible 
3D-SAM ------------------------------------------ three dimensional self assembled monolayer 
1 
 
CHAPTER I 
 
INTRODUCTION 
 
 
Statement of Problem 
 There are currently an estimated 24 million people worldwide that have been 
diagnosed with Alzheimer’s Disease.  Aside from being the most prevalent 
neurodegenerative disease, it is also the third most expensive disease costing the United 
States over $100 billion dollars annually.4
 
  There is currently no definitive diagnosis 
other than an autopsy.  Prevalence of Alzheimer’s Disease is correlated with changes in 
cerebrospinal fluid concentrations of the amyloid beta peptides and tau protein.  A high 
throughput method that is used to determine the concentration of these biomarkers in 
cerebrospinal fluid would assist in assigning a more definitive diagnosis and to track 
disease progression.  
Chapter Overview  
For quantitation of each of the amyloid beta peptides to be possible, they must 
first be separated.  This project involved the production of a pseudostationary phase in a 
capillary electrophoretic analysis to separate these peptides.  The pseudostationary phase 
consisted of 10 nm gold nanoparticles functionalized with an asymmetric disulfide, 10-
(dodecyldisulfanyl) decane-1-sulfonic acid.  Because this disulfide is not commercially 
available, its synthesis and characterization was required.   
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This project began with the synthesis of a sulfonic acid terminated alkyl thiol, 
mercaptodecanesulfonate (MDS).  Following the purification of MDS as well as its 
characterization using NMR spectroscopy, MDS was reacted with dodecanethiol to form 
an asymmetric disulfide.  This coupling was accomplished through the use of a disulfide 
exchange reaction.  The characterization of the asymmetric disulfide was carried out 
using NMR spectroscopy and FTIR spectroscopy. 
The synthesized disulfide was then used to derivatize 10 nm gold nanoparticles. 
The optimal disulfide concentration and derivatization time was determined by allowing 
a range of disulfide concentrations to react with the nanoparticles over time. 
Characterization of the self-assembled monolayer of the disulfide on the gold surface was 
achieved through tracking the shift in the plasmon band using visible absorbance and 
FTIR spectroscopy. 
The detection method for the analysis of the selected biomarkers was laser-
induced fluorescence which required the biomarkers to be derivatized with a fluorescent 
dye.  The amyloid beta peptides were derivatized with an amine reactive fluorescent dye.  
The conditions were optimized to get preferential attachment of the dye to the N-terminus 
of each peptide with minimal attachment to the two lysine side chains on both peptides.  
The number of dye molecules on each peptide was determined by MALDI mass 
spectrometry.  The tau protein was derivatized using a thiol reactive dye because it is a 
large protein that has too many possible reactive sites for an amine reactive dye.  The tau 
protein contains only one cysteine as opposed to 37 possible amine reactive sites making 
a thiol reactive dye more selective for a single attachment. 
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The sulfonic acid functionalized nanoparticles that have been made in this 
research as well as the carboxylic acid functionalized nanoparticles that were synthesized 
prior to this research project were used to effect the separation of the amyloid beta 
peptides, and the tau protein, as well as a mixture of all three biomarkers.  The conditions 
of the separation including the type of buffer, pH, and voltage setting were optimized for 
the detection of the biomarkers. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Capillary Zone Electrophoresis 
 Capillary electrophoresis (CE) involves the movement of ions in a capillary, 
through the application of an electric field.5
The power supply, which is normally set between 5-30 kV, produces the electric 
field which provides the means for the differential migration of analyte ions in solution.  
The ions in solution will have different electrophoretic mobilities depending on their size 
to charge ratios.  Those ions that are of similar size will then be separated according the 
magnitude of their charge.  When the electric field is applied, the analyte ions will 
  A typical CE system consists of a capillary, 
an injector, a high voltage power supply, electrodes, as well as some form of detection.  
Some of the various detection schemes will be discussed in greater detail later.  The 
capillary is where the separation takes place.  The capillary is made of fused silica that is 
roughly 330 µm thick with an inner diameter of 25-75 µm.  Generally, the capillaries are 
50 cm in length from inlet to the detection window and are coated with a polyimide 
coating to make them more durable.  At the detector, the polyimide coating is “burned” 
off to make a detection window for on column detection.  At either end, the capillary sits 
in a vial of buffer solution.  These vials also contain platinum electrodes which are 
connected to a high voltage power source.  The circuit between the electrodes is 
completed in the capillary using a conductive electrolyte solution, normally a 50 mM 
buffer solution.   
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migrate towards the cathode or anode depending on their charge.  Anions in solution will 
travel in the direction of the anode, which is normally at the inlet.  Cations will migrate to 
the cathode, which is at the outlet.  The velocity at which each ion travels is inversely 
proportional to its hydrodynamic radius and proportional to the strength of the applied 
field and the charge on the ion.   This velocity is considered to be the ions electrophoretic 
velocity.   
Another factor that affects the movement of the analyte is the electroosmotic 
flow.  Electroosmotic flow can be described as the flow of solvent in an electric field.  In 
CE, electroosmosis is highly dependent on pH, concentration, and composition of the 
background electrolyte.6  The interior of the capillary has exposed silanol groups (SiOH) 
which can be deprotonated above pH 3.  This gives the inner wall of the capillary an 
overall negative charge.  Cations in the buffer solution will be attracted to the capillary 
walls and will form a double layer to neutralize the charge on the wall.  When the electric 
field is applied, the cation rich double layer will flow towards the cathode.  The double 
layer provides a more plug like flow profile because the flow is generated from the wall.  
This plug like flow profile is beneficial when compared to the parabolic flow profile that 
arises from pressure driven systems, like high performance liquid chromatography 
(HPLC), that leads to band broadening.  The apparent mobility of an ion in capillary 
electrophoresis is the sum of its electrophoretic and electroosmotic mobility.  The 
electroosmotic mobility must be greater than the electrophoretic mobility of the anions in 
order for them to be detected.  In a configuration where the anode was at the inlet and the 
cathode was at the outlet, cations would elute before neutral compounds which would 
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elute before anions.  Cations would elute first because they possess electrophoretic and 
electroosmotic mobility toward the detector.  The anions are negatively charged so they 
will be attracted to the positively charged anode which is at the inlet.  Since the anions 
are attracted to the anode at the inlet, they will spend more time in the capillary and will 
elute last.  The neutral analyte will be carried through the capillary at the velocity of the 
electroosmotic flow.  With this configuration the anions will have an apparent mobility 
that is slower than the electroosmotic flow, cations will have an apparent mobility that is 
faster than the electroosmotic flow, and neutral analytes will have an apparent mobility 
that is equal to the electroosmotic flow.   
Detection in Capillary Electrophoresis 
 There is an array of detection schemes that can be used with capillary 
electrophoresis.  Detection systems are analyte dependent, so each method has its 
advantages and its drawbacks.  The most used detection methods include absorbance, 
fluorescence, mass spectrometry will be discussed below.  However, there are other 
detection methods such as potentiometric, conductivity, amperometric, and refractive 
index. 
Direct Absorbance 
The most common detector for CE separations is the absorbance detector.  It 
works well with compounds that have native absorbance including many organic 
compounds, since most of them will absorb around 195-210 nm.  The buffers used must 
then have little absorbance in this region.  One of the major drawbacks of UV absorbance 
detection is that it is limited by Beer’s Law.  The magnitude of the pathlength is a major 
component of the sensitivity of absorbance measurements.  However, in CE the 
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pathlength of the capillary is so small, 25-75 µm, that there must be an appreciable 
amount of chromophoric analyte present for detection.  The concentration limit of 
detection for direct absorbance in capillary electrophoresis is 10-5-10-6 M.7  Methods have 
been developed to improve detection by increasing the pathlength at the detection 
window.  Z-cells allow for the absorbance measurement to be taken along the length of 
the capillary in the detection window.  Even though this increases the sensitivity, it also 
increases the length of the sample band to the point where peaks must be separated by the 
length of the flow cell or they will overlap.  Another way to increase the pathlength is to 
use a bubble cell, in which the diameter of the capillary at the detector is increased.  A 
different method uses a multireflection cell where two windows are made on opposite 
sides of the capillary about 1.5cm apart.  Between them is a silver coating that reflects the 
laser light from the entrance window through the capillary to the exit window where the 
absorbance measurement is made.8
Indirect Absorbance 
  Even with the extended pathlength, the concentration 
limit of detection for absorbance is still around 10-6 M.3  Ultimately, absorbance 
measurements are restricted by Beer’s law and the difficulties associated with measuring 
small changes in signal against a large background. 
Another configuration for the absorbance detector is to take indirect absorbance 
measurements.  Indirect absorbance is a way to detect analytes that have very little 
absorptivity.  The buffer contains an absorbing species that produce a high background 
signal.  The non-absorbing analyte displace the absorbing species to produce a signal in 
the form of an inverse peak.  The advantage of this technique is that it does not require 
derivatization of non-UV-absorbing species. 
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Direct On-column Laser-induced Fluorescence 
The most sensitive method of detection in capillary electrophoresis is laser-
induced fluorescence (LIF).  The concentration LOD for on-column LIF is 10-13 M for 
chemically derivatized samples and 10-11 M for natively fluorescent analyte.9  One of the 
more sensitive arrangements entails the angle between the excitation laser and 
fluorescence collection to be zero degrees.  In one common configuration an argon ion 
laser is focused into a fiber optic cable which illuminates the capillary.  This illumination 
is realized by focusing the laser onto a dichroic mirror which reflects the light at the 
excitation wavelength onto the capillary.  The emission wavelength from the analyte will 
pass back through the dichroic mirror and emission filters to a photomultiplier tube.  
Having an angle of zero degrees between the excitation and collection reduces the 
scattering by the walls of the capillary.  This arrangement leads to a lower background 
and enhancement of the fluorescence signal.10
For on-column detection, non-fluorescent analyte molecules are chemically 
derivatized with a fluorophore prior to CE analysis.  There is a wide selection of 
fluorescent probes that react with various functional groups including biological thiols 
and primary amines.  Perhaps one of the biggest drawbacks to chemical derivatization is 
that it can lead to multiple labeling of an analyte that has more than one reactive site.  
Multiple labeling of analytes will cause a difference in their electrophoretic mobility 
since the label adds mass and will often times neutralize charge.  While multiple reaction 
sites will increase the signal, the distribution of analytes with different degrees of 
derivatization will lead to multiple peaks for a single analyte.
    
11  There have been 
techniques developed to circumvent this problem.  Pinto and coworkers added a 
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submicellar concentration of SDS to the buffer which effectively homogenized the 
multiply labeled protein analyte to a single peak.12
Direct Post-column Laser-induced Fluorescence 
  The probe involved reacted with 
primary amines allowing it to attach to the N-terminus or ε-amine side chains leading to a 
mixture of derivatized products.  The sulfate group of the submicellar SDS interacts with 
the underivatized primary amines making them effectively neutral and adds 
approximately the same mass as the fluorescent probe.  The SDS corrects for the different 
numbers of attached probes and gives analytes of the same type roughly the same 
electrophoretic mobility so they will migrate under the same peak.  The other technique 
for avoiding the problem of multiple derivatizations is to conduct a post-capillary 
derivatization which falls under the category of post column detection. 
The detection limit for post-column fluorescence is as low as 10-16 M, which is 
considered single molecule detection.3 Post-column fluorescence techniques will 
normally involve a sheath flow cuvette which eliminates the Raleigh and Raman 
scattering from the capillary.  Passing through the cuvette is a buffer which matches the 
refractive index of the sample to decrease scattering that would be caused by a refractive 
index mismatch and the sheath flow helps hydrodynamically focus the fluorescence 
signal.13  The signal is focused to a pinhole through which the fluorescent emission is 
collected, which further reduces scattering.  Post column detection also allows for post-
capillary derivatization.  In this technique, the analyte is derivatized in a reaction cell or 
capillary just prior to detection.  This method requires less sample prep before analysis, 
but requires a fluorogenic reagent that has fast reaction kinetics.  Fluorogenic probes are 
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those that are fluorescent only after reaction with the analyte to avoid a high background 
signal.14
Indirect Laser-induced Fluorescence 
   
Indirect LIF is very similar to the method for indirect absorbance that was 
previously described.  Yeung and Kuhr were the first to employ this technique using a 
background buffer that fluoresces to detect species that do not exhibit native 
fluorescence.15
Mass Spectrometry 
  The non-fluorescent analyte displaces the fluorescent buffer to produce a 
decrease in the fluorescent signal, or an inverse peak.  The detection limits for this 
method are very poor (10-6 M) when compared with other fluorescence detection 
techniques because the background is fairly noisy.  This is due to instability in the laser 
intensity.  The benefit of this setup is that it does not require chemical derivatization.  
There are two major categories of mass spectrometric (MS) detectors for CE.  
There are online and offline detectors.  There are a variety of different interfaces to 
connect the two instruments.  Electrospray ionization is the most popular online means of 
coupling the CE separation with MS.  Perhaps one of the more sensitive systems, 
designed by Mazereeuw et al., has a tapered outlet on the separation capillary that is 
positioned in front of the MS inlet so that the applied field for the separation also acts to 
generate the electrospray.  There is an electrical contact between the tip of the capillary, 
through the air, to the MS which is grounded.16  This setup uses a single high voltage 
power supply to effect the separation and to produce the electrospray or microspray in 
this case.  The LOD for this method is in the nanomolar range.  Other ESI interfaces use a 
sheath flow at the end of the capillary.  Often times the optimized conditions for the 
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separation don’t match the optimized conditions for the MS portion of the experiment.  
The sheath flow interface resolves this problem, allowing the buffer conditions in the 
sheath flow to be optimized for ionization just prior to entering the MS.  The matrix-
assisted laser desorption/ionization mass spectrometer (MALDI-MS) is used as an offline 
MS detection method for CE.  The eluent is continuously deposited on a membrane 
surface that is coated with MALDI matrix.17
Micellar Electrokinetic Chromatography 
  This arrangement is effective, but there is 
some loss of the separation efficiency.   Even though MS detectors are not as sensitive as 
some of the other detection schemes like fluorescence, they provide qualitative as well as 
quantitative information about the analyte, often giving positive identification of the 
analyte.  
 One major drawback of traditional capillary electrophoresis or CZE is that it does 
not allow the separation of neutral species.  The neutral analyte molecules will travel in 
the same band and will have the same migration as the electroosmotic flow since they do 
not have an electrophoretic mobility.  One way to circumvent this problem is to conduct 
micellar electrokinetic chromatography (MEKC).18  This mode of CE involves the 
addition of a surfactant above its critical micelle concentration (cmc) to form micelles.  
Above the cmc, the surfactant will aggregate to form micelles that have their polar head 
groups toward the aqueous phase, and their hydrophobic tails toward each other.  Sodium 
dodecyl sulfate (SDS) is commonly used in MEKC and will be used as an example here.  
Once the sample is loaded, the electric field is applied.  The portion of the micelle that is 
exposed to the buffer has negative charge from each of the deprotonated sulfate groups.  
The negative charge of the sulfate group causes the micelle to have an electrophoretic 
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mobility that is towards the anode/inlet.  Analyte that interacts with the micelle will travel 
at the velocity of the micelle during the time spent in the micelle.  This interaction 
effectively slows the migration time of that analyte.  The more interaction that takes 
place, the longer the migration time will be.  Even though the micelles are not bonded to 
the interior of the capillary, they function the same as a stationary phase in 
chromatography and are given the name pseudostationary phase.  In MEKC, the analyte 
is separated according to two mechanisms.  The first mechanism is the difference in the 
electrophoretic mobility.  The second mechanism of separation is the analyte’s 
partitioning in the hydrophobic core of the micelle.  By this mechanism, MEKC can 
separate neutral compounds as well as compounds that have similar electrophoretic 
mobilities.  Since there is a fairly high concentration of surfactant that is present in the 
eluent, compatibility with MS can be problematic.  The presence of surfactant micelles 
can greatly reduce the sensitivity of the MS.  A solution to this problem has been 
developed where a plug of micelles is injected near the inlet of the capillary.  The analyte 
must then migrate through a plug of micelles then on to the electrophoresis buffer before 
entering the mass spectrometer.19
Capillary Electrochromatography 
 
 Capillary electrochromatography (CEC) is a mode of CE separation that combines 
the selectivity of HPLC with the resolution and efficiency of CE.20  In CEC the 
capillaries are monolithic or packed with small diameter particles or porous beads.  The 
packings are similar to those used in HPLC but smaller diameter particles (<1µm) can be 
used.  One of the bigger problems facing CEC is that it is difficult to pack such small 
particles into a small column in a reproducible manner.  Another drawback to using such 
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small particles is that it decreases the sample loading capacity of the column.  In CEC, it 
is the electroosmotic flow that drives the analyte through the column, not pressure like in 
HPLC, meaning that the flow profile is flat and plug-like instead of parabolic, which 
leads to more efficient separations.  The separation of charged species is dependent on 
the electroosmotic flow, the electrophoretic mobility, as well as the partitioning of the 
analyte into the stationary phase.  For a neutral analyte, the migration will be dependent 
on the electroosmotic mobility and the partitioning of the analyte in the stationary phase.  
Like in HPLC, frits are required on either end of the capillary to keep the particles in the 
column.  These frits tend to cause band broadening and lead to bubble formation.  The 
bubbles are caused by a slight difference in the electroosmotic flow at the interface 
between the packed and unpacked portions of the capillary.  Bubble formation is 
particularly detrimental in CEC because it will stop the electrical current.  This adverse 
effect can be overcome by applying pressure at both ends of the capillary or by using 
monolithic columns.21
Monolithic columns are networks of crosslinked polymer that form a single rod.  
These columns do not require the use of frits to retain the stationary phase in the 
capillary.  In CEC the walls of the capillary are bare so the exposed silanol groups will 
lead to the adsorption of basic analytes.  The silanols could be end-capped, however that 
would lead to a reduction in the electroosmotic flow.  CEC, in a way, combines the best 
of both worlds in having the benefits of having the high efficiency of CE and high 
selectivity of HPLC. 
   
14 
 
Nanoparticles 
 The use of nanoparticles in separation science is becoming an increasingly 
popular trend.  This tendency is most likely due to the fact that nanoparticles have a high 
surface area to volume ratio which is favorable in chromatography due to minimization 
of the resistance to mass transfer.  The nanoparticles can be functionalized with various 
functional groups depending on the surface chemistry of the particle.  The most common 
nanoparticles are made from polymers, silica, and gold.  Gold nanoparticles possess a 
great deal of promise since they are highly stable and have excellent optical sensitivity 
which are advantageous properties for chemical derivatization.22  The affinity of gold for 
organosulfur compounds, more specifically alkylthiols and dialkyldisulfides, makes 
functionalization of gold surfaces particularly straightforward.  Other metals in the same 
periodic group, such as silver and copper, also possess the same chemisorption properties 
but are more easily oxidized.  The chemisorption of thiols or disulfides onto gold surfaces 
has been shown to produce highly ordered monolayers.23  The generation of these self-
assembled monolayers (SAMs) through the adsorption of organosulfur compounds onto 
two dimensional surfaces is a well studied area.24  The properties of the monolayers can 
be varied by changing the functional group on the ω-position of the alkyl thiol.  Mixtures 
of thiols that have different terminal groups can be used to produce a mixed monolayer 
that has various functionalities on the surface of the gold.  The problem with this method 
is that the distribution of each type of thiol onto the surface isn’t necessarily solely 
dependent on its concentration in the mixture.  Smaller chain alkyl thiols on the gold 
surface are more likely to be replaced by longer chain alkyl thiols with more methylene 
groups.25  The chemisorption of asymmetric disulfides allows for even better control over 
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the homogeneity of the surface coverage because the gold surface induces the cleavage of 
the sulfur-sulfur bond to form thiolate bonds with the gold.26  It was demonstrated that 
both halves of an asymmetric disulfide were present in equal proportions on the gold 
surface after chemisorption.27  The principles involved in the production of SAMs are 
similar to those applied in the chemisorption of organosulfur compounds onto three 
dimensional particles (3D-SAMs). The replacement of thiols on the surface of 
nanoparticles is dependent on the relative amount of the thiol and whether or not it 
increases the stability of the particle.  In other words, the thiol that promotes increased 
stability of the nanoparticle will display higher expression on the gold surface.  In the 
formation of 3D-SAMs, monolayers from a mixture of thiols, the degree of adsorption of 
each thiol is dominated by which promotes the stability of the particle, which implies 
thermodynamic control.  On the contrary, the composition of the monolayer that is 
formed from mixed disulfides is more inherently controlled by the kinetics of the reaction 
at the gold surface.28
Characterization of the monolayers on the gold surface can be achieved through a 
variety of methods.  The degree of disulfide adsorption onto the gold nanoparticles can be 
monitored by tracking the local surface plasmon band.  A plasmon is merely a quantum 
of plasma oscillation that is comparable to what a photon is to light.  At the metal surface 
there is a density of free electrons because of the fixed positive ions in the metal.  Under 
irradiation with light the oscillating electromagnetic field from a photon of light causes 
the electrons to undergo oscillation with respect to the positive metal surface.
  This implies that disulfide chemisorption allows for better control 
over the surface properties of the gold. 
29  For a 
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nanoparticle, the frequency of light at which this process is resonant is called the 
localized surface plasmon resonance (LSPR).30  This oscillation decays by either 
radiating its energy through scattering (Mie scattering) or by nonradiative conversion of 
the absorbed light into heat.31  For the noble metals, this absorption occurs in the visible 
region.32  Surface plasmons are very sensitive to changes that occur at the interface 
between the metal and surrounding solvent (water).33  The adsorption of the disulfide 
causes a red shift in the maxima of the surface plasmon band due to the increase in the 
relative size of the particle and because of the change in the refractive index at the 
gold/water interface as the thiolates are formed.  Characterization of the thiolates on the 
particle surface can be realized through FTIR or NMR spectroscopy.  The 13C and 1H 
NMR of functionalized gold nanoparticles shows characteristically broader peaks 
compared to that of the free disulfide or thiol.  This phenomenon is believed to be due to 
the slower rotational velocity of the particle.34  FTIR spectra of alkylthiolates on gold 
particles also have characteristic peaks.  The spectra look similar to the spectra of the free 
thiol or disulfide with a few noticeable differences.  As the monolayer begins to order 
itself through lateral van der Waals interactions with adjacent methylenes, defects can 
form.  An increase in the number of defects causes a shift in the C-H stretching vibrations 
to higher energies.35  Compared to the FTIR spectra of the free thiol/disulfide, the 
chemisorbed thiolates will have lower energy C-H stretches.  The characterization of the 
functionalized gold nanoparticles using these methods will be necessary prior to use as a 
pseudo stationary phase in CE experiments.  
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Alzheimer’s Disease 
 In order to emphasize the possible impact of this study, it is important to be 
familiar with the underlying progression of Alzheimer’s Disease.  Alzheimer’s Disease 
(AD) is a neurodegenerative disease that affects an estimated 24 million people 
worldwide.36
Amyloid Beta Hypothesis 
  The prevalence of the disease increases with age and with the increased 
aging population, AD is becoming a more prominent problem.  The only definitive 
diagnosis for AD involves an autopsy for the presence of the pathological hallmarks. The 
trademarks of Alzheimer’s Disease are the formation of neurofibrillary tangles of 
hyperphosphorylated Tau protein and amyloid plaques of the Amyloid Beta peptide in the 
brain.  The pathology of AD is still somewhat ambiguous, but there are two major 
theories as to the cause of the disease.  The two pathways are the Amyloid Beta 
hypothesis and the Tau hypothesis. 
 The Amyloid Beta peptide (Aβ) is a cleavage product of a transmembrane protein 
called the Amyloid Precursor Protein (APP).  There are three secretases that cleave APP: 
the α-secretase, β-secretase, and γ-secretase (Figure 1).  They each cleave the protein at 
different sites.  There are two processing pathways for APP involving these three 
secretases: an amyloidogenic pathway and a non-amyloidogenic pathway.  The 
amyloidogenic pathway leads to the formation of the Aβ peptide and is the more 
prominent pathway in patients with AD.  The β-secretase cleaves the APP on the 
extracellular domain at one end of the Aβ peptide sequence.  This is followed by the 
subsequent cleavage of APP in the membrane spanning region by the γ-secretase.  The γ-
secretase cleaves at the other end of the Aβ sequence, releasing it into the extracellular 
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space outside the neuron.  The non-amyloidogenic pathway, which is thought to be the 
dominant pathway in healthy individuals, starts with APP cleavage by the α-secretase.  
The α-secretase cleaves APP in the middle of the sequence of what would be the Aβ 
peptide .  Then the γ-secretase cleaves APP in the membrane spanning region.  It is 
important to note that this pathway does not lead to production of the Aβ peptide.  The γ-
secretase has the ability to cleave APP in a couple of locations to produce varying lengths  
 
 
Figure 1. Proteolytic Cleavage of APP 
 
 
 
 
of Aβ (37-42 amino acids) in the amyloidogenic pathway.  The Aβ1-40 is the more 
common, less toxic form of Aβ.  When the γ-secretase cleaves APP after 42 amino acids, 
it liberates the more hydrophobic and more harmful Aβ1-42.  This form of the peptide is 
more prone to aggregation.  When it is released, it starts to adhere to other Aβ1-42 and 
forms soluble assemblies called amyloid derived diffusible ligands (ADDLs).  The 
ADDLs collect more of the Aβ1-42 making them increasingly insoluble.  They are then 
believed to attach to a receptor site on the dendrite which is responsible for receiving 
messages from other neurons.  Being unable to communicate, the neuron loses function 
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and eventually dies.  Ultimately they grow to form insoluble amyloid plaques which are 
one of the hallmarks of AD.  It is now believed that the soluble oligomers of Aβ1-42 are 
more toxic than the insoluble plaques or deposits.37  As the peptides aggregate, their 
relative concentrations in solution will start to decrease.  The amyloid beta cascade is the 
more supported hypothesis.  Mutations in APP have been shown to lead to increased 
formation of Aβ1-42.  This fact implies that there is genetic control over formation of Aβ1-
42 which may lead to plaque formation.  There have also been studies that suggest Aβ has 
a connection to Tau phosphorylation.  One study demonstrated that Amyloid deposits 
may be modulated by lithium which is also a Tau protein kinase inhibitor.38  Another 
study showed that Aβ1-42 can bind to the Tau protein and promote its phosphorylation.39
Tau Hypothesis 
  
This observation provides support to the theory that the amyloid beta cascade precedes 
the Tau pathology.    
 The Tau protein is the other biomarker that is involved in AD.  The normal 
function of Tau is to stabilize microtubules in nerve cells.  The phosphorylation of the 
Tau protein and other microtubule associated proteins causes them to detach from the 
microtubule and leads to its destabilization.  Phosphorylation of these proteins is used in 
the cell as a mechanism for the regulation of microtubule stabilization.  In AD an 
increased hyperphosphorylation of the Tau proteins leads to a substantial detachment 
from the microtubule and results in the destabilization of the microtubules in nerve cells.  
Tau phosphorylation also makes it less susceptible to proteolysis.40  As 
hyperphosphorylated tau proteins increase in number they begin to aggregate and form 
neurofibrillary tangles (NFTs).  The accumulation of these tangles in the neuron results in 
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neuronal death.41  Tau has also been deemed responsible for other forms of dementia.  
This is why some believe that it is Tau that is responsible for the neuronal degeneration in 
AD.42
Biomarkers 
  It is almost certain that both the amyloid beta aggregation and 
hyperphosphorylated Tau are responsible for neuronal death, but the question of which 
comes first still remains. 
 Changes in biochemical processes in the brain can be reflected in the 
cerebrospinal fluid (CSF) since it is in direct contact with the extracellular space of the 
central nervous system.  The concentrations of the AD biomarkers (Aβ1-42, Aβ1-40, pTau, 
tTau) in the CSF can then be used as a means tracking disease progression or to assist 
with providing a more accurate diagnosis of AD.  It has been shown that there is a direct 
correlation between the concentrations of these biomarkers and the onset of AD.  In 
patients that have AD there is a characteristic increase in the total amount of Tau protein 
(tTau) in CSF as well as an increase in the CSF concentration of Tau that is 
phosphorylated at threonine 181 (pTau).  There is also a decrease in the relative amount 
of Aβ1-42 that is found in CSF.43  These findings are consistent with the proposed 
mechanisms since hyperphosphorylation of Tau leads to its dissociation from 
microtubules increasing its concentration in the CSF, and increased production of Aβ1-42 
leads to its aggregation in the brain leading to a decrease in Aβ1-42 concentration.  It has 
been shown that the ratio of Aβ1-42/Aβ1-40 is better associated with the disease than just 
the Aβ1-42 concentration alone.44  Currently the tests for these biomarkers are done using 
an Enzyme-linked immunosorbant assay (ELISA).  Some of the drawbacks associated 
with using this technique are that each test is very time consuming because of its single 
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analyte nature so multiple tests would be required to analyze each of the biomarkers.  
Also, cross-reactivity can lead to false positives and false negatives.  The use of 
antibodies in these ELISA tests causes the tests to be fairly expensive and entail strict 
control over conditions such as pH for valuable results.  There is also a great deal of 
disagreement in values that are obtained from different antibody based tests.45  A high 
throughput analysis for the determination of the relative amounts of these biomarkers can 
greatly assist in a more accurate diagnosis of AD as well as provide a means for tracking 
progression of the disease.  There are currently treatments for AD that are in clinical 
trials, so fast and accurate clinical assays for these biomarkers could also offer 
information about the efficacy of these treatments.
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CHAPTER III 
 
SYNTHESIS AND CHARACTERIZATION OF ASYMMETRIC DISULFIDE 
 
 
Introduction 
 The use of thiols and disulfides in the production of highly ordered self assembled 
monolayers on gold surfaces is a well defined area of research.46
Figure 2
  The use of disulfides in 
particular allows for the production of a monolayer that can have various functionalities.  
In synthesizing functionalized nanoparticles that are to be used in the separation of the 
AD biomarkers, a selective interaction between the biomarkers and nanoparticles would 
be beneficial.  The disulfide that is chemisorbed onto the surface of the nanoparticle 
should then consist of at least one alkyl chain that acts as a point of hydrophobic 
interaction for the biomarkers.  This, in essence, gives the particle reversed phase 
character.  It is advantageous if the monolayer of the functionalized nanoparticles had 
charge associated with it to give the particle an electrophoretic mobility and a point of 
ionic exchange.  The use of a sulfonic acid as the ω-functionality provides this charged 
character.  The advantage of using a sulfonic acid functionality is that it is deprotonated 
at almost every pH giving a higher abundance of negative character to the nanoparticles 
over a wide pH range.  The disulfide shown in  was chosen to be synthesized and 
used in the functionalization of gold nanoparticles because it has the properties that 
would be useful in this type of separation.  The synthesis of the disulfide required the 
synthesis of an alkyl sulfonic acid terminated with a thiol.  This thiol was then reacted 
with an alkyl thiol via a disulfide exchange reagent.
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Figure 2. 10-(dodecyldisulfanyl) decane-1-sulfonic acid 
 
 
 
Materials and Methods 
 The chemicals used in the syntheses were obtained from the following companies:  
Acros Organics (thiourea, 1-dodecanethiol); Alfa Aesar (1,10-dibromodecane, 2,2’-
dipyridyldisulfide); Cambridge Isotope Laboratories (deuterated methanol, deuterated 
dimethylsulfoxide, deuterium oxide); Fisher Scientific (acetone, ethyl ether, petroleum 
ether, potassium bromide, sodium hydroxide, sodium sulfite); Pharmco-AAPER (ethanol 
(90%), ethanol (200 proof)). 
Because the chosen disulfide is not available commercially, it had to be 
synthesized.  The synthesis of the asymmetric disulfide began with the production of the 
functional arm that contains the sulfonic acid.  This functional arm is a sulfonic acid 
terminated alkyl thiol known as mercaptodecanesulfonate (MDS) shown in Figure 3.   
 
 
Figure 3. Mercaptodecanesulfonate (MDS) 
 
 
 
The synthesis of MDS was slightly modified from that reported by Fiurasek and 
Reven.47 Figure 4 The scheme for the synthesis of MDS is shown in  below.  A 5 molar 
excess of dibromodecane (42.4490 g, 0.141 mol) was added to a mixture of 60 mL of 
95% ethanol and 20 mL of nanopure water in a 500 mL triple-neck round bottom flask.  
This mixture was heated to reflux (~80˚C) while being stirred.  Sodium sulfite (3.5500 g,  
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0.0277 mol) was dissolved in 40 mL of nanopure water and was added to a 125 mL 
pressure equalizing addition funnel.  The sodium sulfite solution was added dropwise to 
the refluxing dibromodecane mixture over a period of 3 hours in an effort to only react 
one end of the dibromodecane. After refluxing for an additional 4 hrs the excess 
dibromodecane was separated from the reaction mixture.  The aqueous portion was 
washed with three 25 mL portions of petroleum ether to remove the unreacted 
dibromodecane.  The aqueous portion was then concentrated by rotary evaporation to 
remove the ethanol.  The resulting solution was cold crystallized and the resultant crystals 
were collected by vacuum filtration.  The compound was verified by proton NMR to be 
sodium 10-bromodecanesulfonate (Figure 6).  The mass of the sodium 10-
bromodecanesulfonate was 7.0735 g giving a yield of 96%.  The subsequent reaction 
involved dissolving the 10-bromodecanesulfonate (7.0735 g, 0.0219 mol) in a mixture of 
75 mL of 200 proof ethanol and 25 mL of nanopure water in a 250 mL round bottom 
flask.  An equimolar amount of thiourea (1.6314 g, 0.0219 mol) was added to the mixture 
and the reaction was brought up to reflux (~78˚C) and stirred for 6 hours.  The reaction 
mixture was then concentrated to 25 mL by rotary evaporation and cold crystallized 
giving 5.8692 g of product which relates to a 90% yield.  The resulting solid was 
confirmed by proton NMR to be 10-S-thiouronium decanesulfonate (Figure 7).  10-S-
thiouronium decanesulfonate (5.8692 g, 0.0198 mol) was then dissolved in 60 mL of 10 
mM sodium hydroxide in a 250mL round bottom flask and submitted to a base hydrolysis 
to cleave the C-S bond releasing the alkylthiol and urea.  The reaction was refluxed (~ 
93˚C) and stirred for three hours under an argon stream.  After three hours the reaction 
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mixture was taken off the heat and allowed to cool without stirring overnight under argon 
stream.  The thiol was protonated by acidification with dilute sulfuric acid (0.7 mL of 
concentrated sulfuric acid to 5 mL of water) which was added dropwise to the stirring 
mixture until a pH of 7 was reached.  The solution was then cooled on ice and the 
resultant crystals were obtained by vacuum filtration.  The product had a mass of 4.8828 
g (97%) and was verified by proton NMR (Figure 8), 13C NMR (Figure 11), FTIR (Figure 
12), and HPLC-ESI-MS to be Mercaptodecanesulfonic acid (MDS)(Figure 9, Figure 10).    
 
 
Figure 4. MDS Synthetic Scheme 
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The formation of asymmetric disulfides has been demonstrated using thiol-
disulfide exchange reagents.  These compounds form a disulfide bond with one thiol and 
act as a good leaving group for reaction with a subsequent thiol to produce the desired 
asymmetric disulfide.  The most popular thiol-disulfide exchange reagents are the pyridyl 
disulfides.48  One such compound, 2, 2’-dipyridyldisulfide, has been shown to act as a 
thiol-disulfide exchange reagent in the production of asymmetric disulfides.49
Figure 13
  The thiol 
made in the prior synthesis, MDS, was reacted with a four molar excess of 2, 2’-
dipyridyldisulfide (Figure 5).  The MDS (74 mg, 0.292mmol) was dissolved in a mixture 
of 20 mL of nanopure water and 5 mL of acetone and added to a 125 mL pressure 
equalized addition funnel.  The 2,2’-dipyridyldisulfide (240 mg, 1.09 mmol) was 
dissolved in 15 mL of acetone and added to a 100 mL round bottom flask.  The MDS 
solution was added dropwise to the stirring 2,2’-dipyridyldisulfide mixture at room 
temperature over a period of three hours to reduce the chance of the subsequent reaction 
with the product to form the symmetric disulfide.  When the MDS thiol reacts with the 2, 
2’-dipyridyldisulfide (DPD) it produced the mixed disulfide MDS-pyridyldisulfide and 
releases pyridine-2-thione.  This reaction product, pyridine-2-thione, is 
spectrophotometrically measureable at 343 nm.  This allowed for the reaction progress to 
be tracked by UV absorbance ( ).  Once the absorbance reached a maximum at 
343 nm, the reaction was completed.  The reaction took an additional 4 hours after all of 
the MDS was added to reach completion.  The excess DPD and pyridine-2-thione was 
washed from the reaction mixture using ethyl ether.  The reaction mixture was then 
concentrated by rotary evaporation to 20 mL and cold crystallized to give 84 mg of 
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product, equivalent to a 75% yield.  The product was verified by proton NMR to be 
MDS-pyridyldisulfide.  The MDS-pyridyldisulfide (84 mg, 0.219 mol) was then 
dissolved in 20 mL of nanopure water and was reacted with an equimolar amount of 
dodecanethiol (44 mg, 0.219 mol) dissolved in 20 mL of acetone to produce the 
asymmetric disulfide.  This reaction also produces the pyridine-2-thione byproduct that 
allows for tracking of the reaction to completion.  Upon completion, the pyridine-2-
thione was washed from the reaction mixture using three 10 mL portions of ethyl ether 
and both the aqueous and organic layers were dried for NMR analysis.  The aqueous 
layer consisted mainly of the 10-(dodecyldisulfanyl) decane-1-sulfonic acid (Figure 14).  
The organic layer consisted mostly of pyridine-2-thione and unreacted dodecanethiol.  
The 10-(dodecyldisulfanyl) decane-1-sulfonic acid was then analyzed by FTIR (Figure 
15). 
28 
 
Figure 5. 10-(dodecyldisulfanyl) decane-1-sulfonic acid Synthetic Scheme 
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Results 
 1H and 13C NMR were obtained by dissolving 10 mg of the compound of interest 
in 0.75 mL of the appropriate deuterated solvent (deuterium oxide, deuterated methanol, 
or deuterated dimethyl sulfoxide).  All NMR were obtained using a JEOL 500 MHz 
spectrometer.  Fourier Transform Infrared analysis was conducted using a Nicolet Nexus 
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470 FTIR.  Sample preparation for FTIR involved adding 5 mg of sample to 200 mg of 
dried potassium bromide and which was then pressed into a KBr pellet.  UV Absorbance 
measurements were made using a Cary 100 Bio UV-Visible Spectrophotometer by 
Varian. 
Figure 6 displays the proton NMR of the first synthetic product in the synthesis of 
MDS.  The first peak around 1.3 ppm corresponds to the methylene peak, the next group 
of peaks at 1.8 ppm is two overlapped quintuplets corresponding to the protons beta to 
the sulfonic acid and bromine.  The triplet at 2.7 ppm is the protons alpha to the sulfonic 
acid and the triplet at 3.4 ppm is the protons alpha to the bromine.  The peak in between 
the triplets at 3.29 ppm is a solvent peak. 
 
 
Figure 6. Proton NMR of 10-Bromodecanesulfonate 
 
1H NMR (Methanol D-3) δ 1.3-1.4 (m, 12H, -CH2CH2(CH2)6CH2CH2-), 1.7-1.8 (m, 4H, 
SO3CH2CH2(CH2)6CH2CH2Br), 2.76 (t, 2H, -CH2CH2SO3), 3.40 (t, 2H, -CH2CH2Br) 
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 Figure 7 shows the proton NMR of the second product in the MDS synthesis.  The 
peaks at around 1.3 ppm are the methylene peaks, there are two overlapping quintuplets 
at 1.5-1.6 ppm for the protons beta to the thiouronium and sulfonic acid.  The triplet at 
2.4 ppm is the protons alpha to the sulfonic acid.  The triplet at 3.1 ppm is due to the 
protons alpha to the thiouronium and the doublet at 9.0 ppm is due to the protons on the 
nitrogens. 
 
 
Figure 7. Proton NMR of Thiouroniumdecanesulfonate 
 
1H NMR (Methanol D-3) δ 1.2-1.4 (m, 12H, -CH2CH2(CH2)6CH2CH2-), 1.5-1.6 (m, 4H, 
SO3CH2CH2(CH2)6CH2CH2SC(NH2)2), 2.41 (t, 2H, -CH2CH2SO3), 3.13 (t, 2H, -CH2CH2 
SC(NH2)2), 9.06 (d, 4H, - CH2CH2 SC(NH2)2) 
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Figure 8 shows the proton NMR of the thiol product mercaptodecanesulfonate.  
The methylene peaks are at around 1.3 ppm.  The quintuplet at 1.52-1.57 ppm is due to 
the protons beta to the thiol.  The next quintuplet at 1.65-1.71 ppm is due to the protons 
beta to the sulfonic acid.  The triplet at 2.49 ppm is due to the protons alpha to the thiol.  
The triplet at 2.85 ppm corresponds to the protons alpha to the sulfonic acid. 
 
 
Figure 8. Proton NMR of Mercaptodecanesulfonate 
 
1H NMR (D2O) δ 1.2-1.4 (m, 12H, -CH2CH2(CH2)6CH2CH2-), 1.5-1.6 (m, 2H, -CH2CH2SH), 
1.65-1.75 (m, 2H, -CH2CH2SO3), 2.49 (t, 2H, -CH2CH2SH), 2.85 (t, 2H, -CH2CH2SO3) 
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 Figure 9 shows the total ion chromatogram of the product MDS.  This compound 
was run on an HPLC connected to a mass spectrometer with an electrospray ionization 
source.  This figure shows the compound eluting after 37.28 minutes with a mass of 
252.19.  This particular run was completed in negative mode.  
 
 
Figure 9. Total Ion Chromatogram of MDS run on HPLC-ESI-MS 
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 Figure 10 shows the mass spectrum of the peak at 37.28 minutes in the total ion 
chromatogram shown above.  The major peak in this spectrum is shown at 252.19 m/z 
suggesting the mass of the compound to be 252.19 g/mol.  This spectrum was taken in 
negative mode. 
 
 
Figure 10. ESI Mass Spectra of MDS 
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Figure 11 shows the 13C NMR of the thiol product Mercaptodecanesulfonic acid.  
The carbons are labeled from 1-10 starting at the thiol and ending at the sulfonic acid. 
Carbon 1 peak is at 23.95 ppm, Carbon 2 at 33.04 ppm, Carbon 3 at 27.67 ppm, Carbon 4 
at 28.52 ppm, Carbon 5 at 28.18 ppm, Carbon 6 at 28.37 ppm, Carbon 7 at 28.07 ppm, 
Carbon 8 at 23.78 ppm, Carbon 9 at 27.44 ppm, and Carbon 10 at 51.07 ppm. 
 
 
Figure 11. Carbon NMR of Mercaptodecanesulfonate 
 
13C NMR (D2O) δ 23.78 (-CH2CH2SO3), 23.95 (SH CH2-), 27.44(-CH2SO3), 27.67       
(SH(CH2)2CH2-), 28.07 (-CH2(CH2)3SO3), 28.18 (SH(CH2)4CH2-), 28.37 (-CH2(CH2)4SO3), 
28.53 (SH(CH2)3CH2-), 33.04 (SHCH2CH2-), 51.08 ( SO3-CH2) 
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Figure 12 shows the FTIR of MDS.  The broad peak around 3400 cm-1 is most 
likely due to moisture in the sample.  The asymmetric and symmetric methylene stretches 
are at 2920 and 2850 cm-1 respectively.  The stretch from the methylene to the sulfur 
groups is shown at 1460 cm-1.  The peaks at 1184 and 1062 cm-1 correspond to the 
asymmetric and symmetric stretch between the sulfur and oxygen on the sulfonate group.  
The peak at 616 cm-1 corresponds to the carbon sulfur stretch. 
 
 
Figure 12. FTIR of Mercaptodecanesulfonate 
 
3400 cm-1 [moisture]; 2920 cm-1 [asymmetric CH2 stretch]; 2850 cm-1 [symmetric CH2 stretch]; 
1460 cm-1 [CH2-S stretch]; 1184 cm-1 [asymmetric S=O stretch]; 1062 cm-1 [symmetric S=O 
stretch]; 718 cm-1 [CH2 rock]; 616 cm-1 [C-S stretch]. 
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Figure 13 displays the UV-Vis absorption measurements that were used to track 
the 2,2’-dipyridyldisulfide exchange reaction with mercaptodecanesulfonate.  As each 
sample was taken there was an increase in the relative absorbance signifying the release 
of the pyriyl-2-thione byproduct that has an absorbance around 343 nm.  As the reaction 
came to completion the intensity of the absorbance started to level off at around 2.7 
relative absorbance units.  
 
 
Figure 13. UV-Vis Absorbance of MDS-pyridyldisulfide Reaction Over Time 
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Figure 14 shows the proton NMR that was used to characterize the disulfide 
product as 10-(dodecyldisulfanyl) decane-1-sulfonic acid.  The triplet at around 0.8 ppm 
corresponds to the methyl protons.  The peak from 1.2-1.4 is associated with the 
methylene protons.  The quintuplet at 1.65 is the protons beta to the thiol and the 
quintuplet at 1.77 is the protons beta to the sulfonic acid.  The triplet at 2.66 is the 
protons alpha to the thiol and the triplet at 2.7 ppm is the protons alpha to the thiol.  It is 
important to point out that upon formation of a disulfide, the thiol peaks shift from 
around 2.4 further downfield to 2.66 implying that the disulfide has been formed.  Also 
the integration of the peaks alpha and beta to the disulfide and sulfonic acid show that the 
disulfide peaks have roughly twice as much area since there are two of them. 
 
Figure 14. Proton NMR of 10-(dodecyldisulfanyl) decane-1-sulfonic acid 
 
1H NMR (CD3OD, TMS) δ 0.89 (t, 3H, -CH2CH2CH3), 1.25-1.46 (m, 30H, CH3(CH2)9CH2CH2S-
SCH2CH2(CH2)6CH2CH2SO3), 1.67 (m, 4H, -CH2CH2S-SCH2CH2-), 1.77 (m, 2H, -CH2CH2SO3), 
2.67 (t, 4H, -CH2CH2S-SCH2CH2-), 2.77 (t, 2H, -CH2CH2SO3) 
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Figure 15 shows the FTIR of the asymmetric disulfide 10-(dodecyldisulfanyl) 
decane-1-sulfonic acid.  The broad peak around 3400 is due to moisture in the sample.  
The asymmetric and symmetric CH2 stretches, at 2919 and 2849 cm-1 respectively, have 
increased in intensity when compared to the thiol that was synthesized previously.  This 
is expected due to the added methylenes from the dodecyl portion of the disulfide.  The 
peak at 1470 cm-1 corresponds to the CH2-S stretch from the disulfide and sulfonic acid.  
The asymmetric and symmetric S=O stretches are shown at 1168 and 1061 cm-1 
respectively.  The CH3 deformation is shown at 1219 cm-1.  The C-S stretch and S-S 
stretches are shown at 614 and 524 cm-1 respectively.  
 
 
Figure 15. FTIR of 10-(dodecyldisulfanyl) decane-1-sulfonic acid 
 
3400 cm-1 [moisture]; 2919 cm-1 [asymmetric CH2 stretch]; 2849 cm-1 [symmetric CH2 stretch]; 
1470 cm-1 [CH2-S stretch]; 1219 cm-1 [CH3 deformation]; 1168 cm-1 [asymmetric S=O stretch]; 
1061 cm-1 [symmetric S=O stretch]; 614 cm-1 [C-S stretch]; 524 cm-1 [S-S stretch] 
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Conclusion 
 The synthesis of initially the thiol mercaptodecanesulfonate and ultimately the 
desired disulfide, 10-(dodecyldisulfanyl) decane-1-sulfonic acid, was achieved and 
verified by NMR and FTIR analysis.  The synthesis of the asymmetric disulfide was 
made possible through the use of a thiol-disulfide exchange reagent, 2,2’-
dipyridyldisulfide. 
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CHAPTER IV 
 
DERIVATIZATION OF GOLD NANOPARTICLES 
 
 
Introduction 
The next step in the project involved the production of the pseudostationary phase 
to be used as the means of separation of the amyloid beta peptides.  Assembly of this 
pseudostationary phase required the chemisorption of 10-(dodecyldisulfanyl) decane-1-
sulfonic acid onto 10 nm gold nanoparticles.  The chemisorption of disulfides onto gold 
surfaces provides an ordered monolayer of the arms of the disulfide on the surface.  The 
use of bifunctional disulfides allows for control over the functional properties of the 
monolayer.50
Figure 16
  Characterization of the monolayer can be performed using NMR 
spectroscopy and FTIR spectroscopy.  The degree of adsorption of the disulfide on the 
gold surface can be followed by tracking the UV maxima of the plasmon band.  A 
solution of the 10-(dodecyldisulfanyl) decane-1-sulfonic acid was mixed with the citrate 
stabilized nanoparticles and the degree of adsorption was detected through the shift in the 
plasmon band.  A proposed schematic of the functionalized nanoparticle is shown in 
.  Conditions such as the time of derivatization and the concentration of the 
disulfide were optimized for maximum coverage of the particles while still maintaining 
particle stability in solution.
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Figure 16. 10-(dodecyldisulfanyl) decane-1-sulfonic acid Functionalized Gold 
Nanoparticles 
  
 
 
 
Prior to these experiments, carboxylic acid functionalized nanoparticles were 
synthesized that had some solubility issues in the aqueous medium.  The sulfonic acid 
terminated nanoparticles seemed be more stable in the aqueous buffers required for the 
electrophoretic analysis because they stayed in solution for a longer period of time. 
Materials and Methods 
 The chemicals used in the nanoparticle derivatization were obtained from the 
following companies: Acros Organics (dodecanethiol); Fisher Scientific 
(tetrahydrofuran); Sigma (10 nM gold nanoparticles).  The mercaptodecanesulfonate and 
10-(dodecyldisulfanyl) decane-1-sulfonic acid were synthesized in house. 
 Because of gold’s affinity for sulfur containing compounds, the functionalization 
of gold nanoparticles is relatively straight forward.  Thiols or disulfides will readily form 
thiolate bonds with the gold surface creating a self-assembled monolayer upon mixing a 
solution of the organosulfur compound with the colloidal suspension of nanoparticles.  
The first test was to see what concentration of disulfide would be optimal to promote self 
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assembly of the monolayer while still maintaining particle suspension.  This can be 
achieved by tracking the surface plasmon band using an absorption spectrophotometer. 
The normal maxima for the plasmon band of 10 nm gold nanoparticles is 520 nm.  Upon 
the chemisorption of the disulfides, this plasmon band exhibits a shift to longer 
wavelength (~530 nm).  This shift in the wavelength is due to the increase in the relative 
size of the particle as well as a change in the refractive index at the metal surface.  The 
greater number of thiols that adsorb onto the surface, the greater the shift will be.  This 
would appear as a decrease in the relative absorbance of the plasmon band.  To achieve 
functionalization of the nanoparticles, the visible absorption spectra of 2 mL of 10 nm 
citrate stabilized gold nanoparticles were measured using a Cary 100 Bio UV-Visible 
Spectrophotometer by Varian.  A 200 µL volume of a range of concentrations of the 
disulfide (1 mM, 10 mM, 50 mM, and 100 mM in water) were then added to the 
nanoparticles and vortexed vigorously.  The mixture was then allowed to sit at room 
temperature for two hours.  After that time the plasmon band maxima was once again 
measured.  To determine the optimal derivatization time 200 µL of 10 mM disulfide was 
added to 2 mL of citrate stabilized 10 nm gold nanoparticles and the localized surface 
plasmon band was measured over time from 1 hr to 24 hr.  With the optimized disulfide 
concentration and derivatization time, the functionalized nanoparticles were then spun 
down using a Savant refrigerated microcentrifuge at 13000 g for 60 minutes.  The 
supernatant was then drawn off leaving the nanoparticle pellet.  The pellet was then dried 
and analyzed by FTIR using the diffuse reflectance attachment.  Once the derivatization 
was complete, the nanoparticles were centrifuged at 13000 g for 60 minutes, the 
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supernatant was removed and the particles were redissolved in the appropriate run buffer 
for use in the capillary electrophoresis experiments. 
Results 
 In order to determine the concentration dependence of the disulfide in the 
functionalization of the 10 nm gold nanoparticles, the reaction was allowed to take place 
using a range of concentrations.  The surface plasmon band was tracked over the range of 
derivatization conditions and as shown in Figure 17.  The 1 mM disulfide solution didn’t 
appear to shift the plasmon band from that of the citrate stabilized particles.  The 10 mM 
solution exhibited a red shift of roughly 2 nm in the wavelength.  This is consistent with 
the increase in particle size due to the adsorption of the disulfide onto the gold surface.  
The decrease in the intensity could be due to increased particle aggregation after 
functionalization.   The higher concentrations showed a greater increase in the plasmon 
band maxima, but at the cost of increased aggregation.  Based on these results it was 
determined that 200 µL of a 10 mM solution of the disulfide mixed with 2.0 mL of 5.7 x 
10-12 particles/cm3 of 10 nm gold nanoparticles provides the optimum tradeoff between 
functionalization and particle stability. 
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Figure 17. Effects of 10-(dodecyldisulfanyl) decane-1-sulfonic acid concentration on 
Nanoparticle Derivatization 
 
 
  
 
The optimal derivatization time was determined by tracking the red shift in the 
maxima of the localized surface plasmon band over time.  The results are displayed in 
Figure 18.  This spectrum shows that hour by hour the plasmon band red shifts to longer 
wavelength.  After 12 hours of derivatization the maxima had shifted from 516 nm to 526 
nm.  After that the maxima did not shift much farther but the intensity began to decrease 
most likely because of destabilization of the particles.  This result implies that roughly 12 
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hours of derivatization time is optimal for functionalizing the nanoparticles with this 
particular disulfide. 
 
 
Figure 18. Effects of Nanoparticle Derivatization Time 
 
 
 
 
Conclusion 
 The chemisorption of the previously synthesized asymmetric disulfide onto 10 nm 
gold nanoparticles was realized.  The conditions for the functionalization of the 
nanoparticles were optimized for the concentration of the disulfide required and for the 
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length of the derivatization.  The conditions for the derivatization reaction were 
optimized by tracking the effect that they had on the localized surface plasmon band.  
Increased adsorption leads to a red shift in the plasmon band caused by the increase in the 
particle size.  It was discovered that a 10 mM solution of disulfide when mixed with the 
gold nanoparticles provides the best particle coverage with little effect on the colloidal 
stability.  A 12 hour reaction time was shown to allow for the largest shift in the plasmon 
band with minimal change in the particles’ ability to stay in solution.
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CHAPTER V 
 
DERIVATIZATION OF BIOMARKERS 
 
 
Introduction 
 The biomarkers themselves do not exhibit enough native fluorescence for 
quantitative measurement.  This implies that in order to use laser-induced fluorescence as 
the CE detection method, the peptides/proteins must be derivatized with a fluorophore.  
Perhaps the more common derivatizing dyes are those that are amine reactive.  In 
proteins they would react with uncharged primary amines such as the N-terminus and 
lysine side chains at a pH greater than their pKa.  One of two probes that were used in the 
amine derivatization of the amyloid beta peptides either the DyLightTM dye that has an 
NHS ester moiety or ATTO-TAGTM FQ.  The amyloid beta peptides have two residues 
and an N-terminus giving them three possible reactive sites for an amine reactive probe.  
As mentioned previously, the availability of multiple derivatization sites gives a 
distribution of the number of attached probes.  This also means that the various degrees 
of derivatization will each have a different electrophoretic mobility, leading to multiple 
peaks for the same analyte.  Management of the pH during the derivatization can give 
priority of attachment to the N-terminus over that of the side chains.  The pKa of the 
lysine side chain is close to 10.5 where the pKa of the N-terminus is close to 7.8.  By 
conducting the derivatization closer to the pKa of the N-terminus, it was thought that the 
peptides would be more selectively labeled at the N-terminus.  The optimal pH for the 
derivatization was determined by conducting the derivatization at various pH’s and 
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determined the number of probes attached by using MALDI-MS.  The MALDI-MS 
spectra of the derivatized peptides were compared to the spectra of an underivatized 
sample to determine the number of attached probes.  The Tau proteins were derivatized 
using a thiol reactive probe.  This allows for better selectivity of the probe attachment as 
well as better resolution during the electrophoretic analysis because there is only one 
available derivatization site, cysteine, on the protein.  This implies that the single 
derivatization site would lead to a single detectable peak.  The conditions of this 
derivatization were based on the literature from the dye manufacturer.  The derivatized 
Tau protein was also analyzed by MALDI-MS and compared to the spectra of an 
underivatized sample to ensure the attachment of a single probe per protein. 
Materials and Methods 
 The materials used in this project were obtained from the following companies: 
Acros Organics (CAPS, dimethylformamide, MES, potassium cyanide, trifluoro acetic 
acid); Fisher Scientific (acetonitrile, ammonium hydroxide, potassium phosphate 
monobasic); GE Healthcare (10 K spin filter, 30 K spin filter); Molecular Probes (ATTO-
TAGTM FQ); Pharmco AAPER (methanol); rPeptide (Amyloid Beta 1-40, Amyloid Beta 
1-42, Human Tau-352); Sigma Aldrich (α-cyano-4-hydroxycinnamic acid, dimethyl 
sulfoxide, sodium tetraborate); Thermo Scientific (DyLightTM 488 NHS Ester, DyLightTM 
488 Maleimide). 
 The Tau protein fluorescent derivatization was achieved using a thiol reactive dye 
(DyLightTM 488 Maleimide) because the protein has a single cysteine allowing for a 
single derivatization.  Upon receipt, 100 µg of Human Tau-352 was reconstituted in 100 
µg of nanopure water to give a protein concentration of 1 mg/mL in 50 mM MES buffer 
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at pH 6.8, 100 mM sodium chloride, and 0.5 mM EDTA.  The DyLightTM 488 maleimide 
(1 mg) was dissolved in 100 µL of dimethylformamide (DMF).  Then 20 µL of the dye 
were added to the 100 µL of peptide and vortexed.  The derivatization reaction was then 
allowed to proceed overnight (~10 hr.)  The non reacted dye was removed by adding the 
mixture to a 30 kDa molecular weight cutoff spin filter for 30 minutes at 9000 g.  The 
filtrand was then washed 3 times with 100 µL portions of 10 mM sodium borate at pH 
10.0.  The resulting filtrand was reconstituted in 100 µL of 10 mM sodium borate at pH 
10.0.  The 100 µL of derivatized Tau at a concentration of 27 µM was divided into 20 
single use fractions of 5 µL.  These were then dried using a Savant Speed Vac (SC110) 
with no heating and stored at -20˚C for later use. 
 The amyloid beta peptides (1 mg Aβ40 and 1 mg Aβ42) were originally 
reconstituted in 1 mL of 1% ammonium hydroxide to give the peptides at a concentration 
of 1 mg/mL (231 µM Aβ40 and 222 µM Aβ42).  Once they were dissolved they were 
sonicated for 30 seconds to 1 minute.  These solutions were either used directly in the 
derivatization with the DyLightTM 488 NHS ester or they were separated into 20 µL 
fractions for later derivatization with ATTO-TAGTM FQ.  The 20 µL Aβ40 fractions were 
diluted with 23.1 µL of 18.65 mM sodium tetraborate at pH 10 to give 200 µM Aβ40 in 
10 mM sodium tetraborate at pH 10.  The 20 µL fractions of Aβ42 were diluted with 22.2 
µL of 10 mM sodium tetraborate at pH 10 to give 200 µM Aβ42 in 10 mM sodium 
tetraborate at pH 10.   These fractions were then stored at -20˚C for later use. 
 To derivatize the amyloid beta peptides with the DyLightTM amine reactive dye, 
the 1 mL of peptide was diluted with 100 µL of 550 mM Borate.  This gave the peptide in 
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0.05 M sodium borate buffer at pH 8.5.  Then 100 µL of either Aβ40 or Aβ42 were added 
to the vial containing 50 µg of the dye.  The resulting solution was mixed well and 
incubated at room temperature for 1 hour.  The excess dye was then removed using a 3 
kDa cutoff spin filter.  The filtrand was rinsed three times with 200 µL portions of 10 
mM sodium tetraborate then reconstituted with 1 mL of 10 mM sodium tetraborate buffer 
at pH 10.  The derivatized peptides were then separated into 40 µL aliquots and dried by 
speed vacuum with no heat.  The aliquots were stored at -20˚C for later use. 
 For derivatization of the amyloid beta peptides with ATTO-TAGTM FQ, a 10 mM 
solution of the ATTO-TAGTM FQ was prepared by dissolving 10 mg of FQ in 4.0 mL of 
methanol.  The dye solutions were then divided up into 10 µL aliquots, dried using a 
speed vacuum, and stored at -20˚C until later use.  The derivatization buffer was 
prepared by dissolving potassium cyanide in 10 mM borate buffer at pH 10 to give 10 
mM KCN.  When required for derivatization, an aliquot of the dye was redissolved in 10 
µL of methanol to give 10 mM dye.  Then 20 µL of the derivatization buffer was added 
to 4 µL of the peptide.  The 10 µL of dye was then added to the peptide solution, the 
solution was mixed, and allowed to sit at room temperature for 1 hour.  After one hour 
the solutions were diluted to give the desired concentration of peptide using the 
appropriate concentration of run buffer so that the final concentration of buffer in the 
sample was 1/10 of what the background electrolyte in the CE experiment was going to 
be. 
In order to determine the pH dependence of the derivatization, the above 
procedure was carried out using 10 mM sodium tetraborate buffer at pH 7.0, 7.5, 8.0, 8.5, 
51 
 
9.0, 9.5, 10.0, 10.5, and 11.0.  After the one hour derivatization time the samples were 
diluted with nanopure water to give the peptides at 25 µM.  The MALDI matrix that was 
chosen was α-cyano-4-hydroxycinnamic acid, which was prepared by dissolving 8 mg in 
1 mL of matrix diluent (50 % acetonitrile, 0.1% trifluoro acetic acid in water). The matrix 
was vortexed vigorously for 30 seconds and centrifuged at 1000 g for 2 minutes.  To 
prepare the samples for spotting, 1 µL of the peptide was mixed with 12 µL of matrix 
diluent, and 12 µL of the supernatant from the centrifuged matrix solution to give the 
peptide samples at 1 µM on the plate.  From these solutions, 0.5 µL were spotted onto a 
clean and dry MALDI plate and the spots were allowed to dry for subsequent analysis on 
an Applied Biosystems 4700 MALDI-TOF. 
Results 
 For the tau protein, probe attachment was verified by electrophoretic analysis.  
Multiple analyses on both the filtrand and the filtrate of the tau derivatization showed that 
the filtrand (protein) had a different electrophoretic mobility than the filtrate (excess dye).  
Both the filtrate and filtrand diluted so that the sample buffer concentration was 4 mM 
borate at pH 10.  They were then hydrodynamically injected into a 67 cm capillary with 
an inner diameter of 50 µm.  The voltage for this analysis was set to 25 kV.  This result is 
shown in Figure 19 with the protein (green trace) having an elution time of 5.8 minutes 
and the dye (red trace) eluting at 4.8 minutes.  Note that the mobilities differ by roughly 
one minute and there is no trace of the excess dye appearing in the tau analysis.  The 
electropherogram for the filtrate (excess dye) was verified to be the DyLightTM 
maleimide through a subsequent analysis of the pure dye (not shown) where the 
electrophoretic peak of the pure dye aligned with the peak for the filtrand at 4.8 minutes.    
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Figure 19. Electropherogram of Tau and DyLight™Maleimide 
 
 
 
 
In order to determine the pH dependence of the derivatization of the amyloid beta 
peptides with ATTO-TAGTM FQ, multiple derivatizations were conducted where the only 
variable was the pH of the derivatization buffer which varied every 0.5 pH units from 7.0 
to 11.0.  After derivatization the samples were mixed with MALDI matrix as described  
above and spotted onto a MALDI plate for analysis by mass spectrometry.  Since there 
are three possible derivatization sites on the amyloid beta peptides (N-terminus and two  
lysine side chains), it was expected that there would be distribution of masses 
corresponding to the attachment of 0-3 molecules of FQ.  The reaction of ATTO-TAGTM 
FQ with an uncharged primary amine is displayed in Figure 20.   The attachment of the 
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Figure 20. ATTO-TAG FQ Reaction 
 
 
 
 
tag to the protein or peptide results in a mass difference of approximately 242 g/mol.  On amyloid 
beta 40, which has a mass of 4328.8 Da, this corresponds to masses of 4328.8 Da, 4570.8 Da, 
4812.8 Da, and 5054.8 Da for the attachment of 0 probes, one probe, two probes, and three 
probes respectively.  For amyloid beta 42, the attachment of ATTO-TAGTM FQ corresponds to 
masses of 4514.8 Da, 4756.8 Da, 4998.8 Da, and 5240.8 Da for the attachment of no probes, one 
probe, two probes, and three probes respectively.  When attempting to determine the molecular 
weight of the amyloid beta peptides prior to and after derivatization, the signal appeared to be 
weak for Aβ42.  This was contributed to increased aggregation of this longer peptide.  A previous 
study showed that the peptides would be in their monomeric form if they were originally 
reconstituted in pure dimethylsulfoxide (DMSO) rather than 1% ammonium hydroxide.51  From 
that point the peptides were initially reconstituted in DMSO and the signal for the peptides was 
much stronger.  It was expected that by derivatizing the peptides at a pH that is closer to the pKa 
of the N-terminus (pH=7.5) and below the pKa of the lysine side chains (pH=10.5), there would 
be a more selective attachment of the probe to the N-terminus.  This would appear as an increase 
in the area of the peak corresponding to a single probe attachment.  The results were, however, 
somewhat counterintuitive.  The data in Table 1 show the percentage of tags that were attached to 
amyloid beta 40 and amyloid beta 42 based on a ratio of the MS peak areas.  These results could 
be rationalized by the pH, in some way, affecting the availability of the derivatization site for dye 
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attachment.  The tables do, however, show that for both peptides, pH 10.5 gives the highest 
ratio of a single peak which corresponds to the attachment of two dye molecules. This 
implies that in an electrophoretic experiment 95% of the peptides will travel under the 
 
Table 1. pH dependence of Amyloid Beta derivatization 
 
 
 
 
same peak corresponding to the peptide with two dye molecules attached.  Only 5% 
would travel under a separate peak relating to single dye attachment.  Because this pH 
gives the highest likelihood of a single electrophoretic peak, it was chosen for further 
derivatizations.  Figure 21 shows the MALDI mass spectra in positive linear mode for a) 
underivatized Aβ40, b) the derivatization of Aβ40 at pH 7.0 which shows the masses of the 
different extents of derivatization, and c) the derivatization of Aβ40 at pH 10.5 which 
gives mostly (~95%) the signal for two dye attachments with a smaller peak (~5%) for 
the single dye attachment.  Figure 22 displays the MALDI mass spectra in positive linear 
mode for a) the underivatized Aβ42, b) the derivatization of Aβ42 at pH 9.0 which shows 
the masses of the different extents of derivatization, and c) the derivatization of Aβ42 at 
pH 10.5 which shows mostly two dye attachments (~94%) and a smaller peak for a single 
dye attachment (~6%).   
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Figure 21. MALDI-TOF MS Spectra of Amyloid Beta 1-40 
 
56 
 
Figure 22. MALDI-TOF MS Spectra of Amyloid Beta 1-42 
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Conclusion 
 The derivatization of the amyloid beta peptides and tau protein were initially 
conducted using the appropriate DyLightTM dye.  This dye was sufficient for the Tau 
protein, however due to its large size it inhibited the separation of the amyloid beta 
peptides.  Because of this the peptides were derivatized with a smaller dye, ATTO-
TAGTM FQ.  The analysis of the derivatization of these peptides over a range of pH 
values using MALDI showed that the high pH derivatizations exhibited the highest 
MALDI signal as well as the most monodispersity in the molecular weights.  Because of 
this, pH 10.5 was chosen as the optimal pH for the derivatization of the amyloid beta 
peptides. 
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CHAPTER VI 
 
CE SEPARATION OF BIOMARKERS USING  A NANOPARTICLE 
PSEUDOSTATIONARY PHASE 
 
 
Introduction 
 In this portion of the research, the nanoparticles that were functionalized with 10-
(dodecyldisulfanyl) decane-1-sulfonic acid were implemented as a pseudostationary 
phase in the capillary electrophoretic analysis of the Alzheimer’s Disease biomarkers.  
The main goal in using the functionalized nanoparticles was to achieve separation 
between the two amyloid beta peptides.  The principles behind the separation are a 
combination of MEKC and CEC.  The nanoparticles act like the micelle pseudo 
stationary phase of an MEKC experiment, but will be more stable since the stationary 
phase is bonded to the particles as in CEC.  On the surface of the particles are the 
alternating arms of the asymmetric disulfide: a 12 carbon alkyl chain and a 10 carbon 
alkyl sulfonic acid.  Since the sulfonic acid is deprotonated at almost every pH, the 
charge around the outside of the particle will be negative.  When the electric field is 
applied the nanoparticles begin to migrate towards the anode which is at the inlet.  The 
proteins and peptides in the sample plug have an overall positive charge and will have an 
electrophoretic mobility in the direction of the cathode because of the high pH of the run 
buffer and sample buffer (pH 10).  Under these conditions the nanoparticles and 
biomarkers are migrating in opposite directions, the interactions between the 
proteins/peptides and the nanoparticles are exploited.  The dodecane arms act as a site of 
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hydrophobic interaction and the sulfonic acid acts as an ion exchange site between the 
biomarkers and the nanoparticles.  The nanoparticles allow for the separation of the 
analyte according to its partitioning into the stationary phase.  The more the biomarkers 
interact with the nanoparticles; the closer the biomarkers’ retention time will be to that of 
the nanoparticles.  The analysis conditions were optimized for the separation and 
quantitation of the amyloid beta peptides and were compared to runs without the pseudo 
stationary phase as a proof of concept.  Conditions were then optimized for the 
quantitation of the total tau protein with the nanoparticles.  This analysis was also 
compared to a control run without the nanoparticles.  An experiment was then conducted 
for the separation of a mixture of the amyloid beta peptides and the tau protein.   
Materials and Methods 
 The chemicals that were used in this section were obtained from the following 
companies: Acros Organics (CAPS, MES); Fisher Scientific (sodium hydroxide); 
Pharmco AAPER (hydrochloric acid). 
 The separation of the Alzheimer’s Disease biomarkers was realized using functionalized 
gold nanoparticles as a pseudostationary phase in a capillary electrophoretic experiment.  Shown 
in Figure 23 is a representation of the interaction between the peptides and the nanoparticles.  
This figure shows three different snapshots of the capillary at different time points in the 
separation.  Right after injection (t=0), the peptides are mixed and would be coeluting if detected 
at that point.  After the voltage is applied the nanoparticles are going to have a large 
electrophoretic mobility towards the inlet because of the sulfonic acid, while the electroosmotic 
flow will be towards the outlet.  Later on in the capillary the peptides will be selectively 
interacting with the particles either through hydrophobic or ion exchange interactions causing the 
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peaks to start to separate (t=5).  By the time the peptides reach the detector in the last part of the 
figure they should have achieved separation (t=10).  
 
Figure 23. Mechanism for the Separation of AB40 from AB42 
 
 
 
 
 The instrumentation and parameters that are to be described were consistent 
throughout all of the CE analyses unless otherwise specified.  The capillary had a 50 µm 
inner diameter and an effective length of 50 cm from inlet to detector with a total length 
of 67 cm from inlet to outlet.  The capillary was installed in a Groton Biosystems 
GPA100 CE with a Picometrics Zetalif LIF-SA-03 detector.  The laser used to induce the 
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fluorescence was a Melles Griot 43 Series Argon Ion Laser connected to the detector via 
optical cable.  The excitation wavelength was set to 488 nm with a light controlled 
excitation power of 10 mW.  The capillary was preconditioned upon installation by 
flushing the capillary with 0.2 M sodium hydroxide for 30 minutes at 1000 mbar.  In 
between analyses the capillary was flushed with 0.1 M sodium hydroxide for 5 minutes, 
nanopure water for 5 minutes, and run buffer for 5 minutes each at 1000 mbar.  In order 
to maintain retention time reproducibility the outlet vial was removed before and replaced 
after flushing with sodium hydroxide to keep the buffer pH consistent.  Sample injections 
were made hydrodynamically at 100 mbar for 3 seconds.  A three second injection time at 
this pressure gives an injection volume of 8.86 nL which corresponds to an injection plug 
length of 4.50 mm.  The background electrolyte (BGE) was either 40 mM CAPS buffer at 
pH 10.0 or 40 mM MES buffer at pH 5.0.  These buffers also contained functionalized 
nanoparticles for some analyses.  The sample buffers were kept at 1/10 the concentration 
of the BGE in order to exhibit sample stacking. 
 The amyloid beta peptides and the tau protein were originally derivatized with the 
appropriate DyLightTM dye and analyzed by capillary electrophoresis using a 40 mM 
CAPS buffer at pH 10.0 both with and without the 10-(dodecyldisulfanyl) decane-1-
sulfonic acid functionalized nanoparticles.  The potential across the capillary was initially 
set to 25 kV.  Despite exhibiting a delayed elution time when analyzed with the 
functionalized nanoparticles in the buffer, the conditions were not sufficient to separate 
the amyloid beta peptides. 
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 The amyloid beta peptides were then derivatized using the smaller ATTO-TAGTM 
FQ and analyzed by CE with 40 mM MES pH 5 as the background electrolyte.  This 
same buffer was used to suspend the functionalized gold nanoparticles for runs where the 
pseudostationary phase was used.  Since decreasing the applied voltage increases the 
retention time52
Results 
, the potential across the capillary was also lowered to 10 kV to allow 
more time for interaction between the particles and the biomarkers. 
 The CE analysis of Aβ40 (100 nM), Aβ42 (100 nM), and tau protein (10 nM) each 
derivatized using the DyLightTM dye with the CAPS buffer at pH 10 showed no 
separation of the amyloid betas (Figure 24).  Both the Aβ40 and Aβ42 eluted at close to 5 
minutes.  There is a second peak that elutes at around 6.6 minutes that has been 
accredited to excess dye either left over from the derivatization or that was hydrolyzed  
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Figure 24. Electropherogram of Tau, AB40, AB42, and mix (DyLight™) without 
nanoparticles
 
 
 
 
from the peptides.  This conclusion was confirmed by CE analysis of the NHS ester of 
the dye under the same electrophoretic conditions which eluted at 6.6 minutes.  It can be 
seen that the peak height of the peptides (5.1 minutes) is roughly doubled in the analysis 
of the mixture (pink trace) when compared to each of the separate analyses (blue trace for 
Aβ40, red trace for Aβ42) implying that the peptides are coeluting which is expected under 
these conditions.  The tau protein is easily separated from the peptides and elutes at 
around 5.9 minutes (green trace).  It also doesn’t appear to effect the migration time of 
the peptides. 
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 Under the same conditions as above, the analysis was repeated, only this time the 
run buffer contained the functionalized gold nanoparticles.  As shown in Figure 25, the 
elution times have been shifted to later times, by a little over a minute.  This shift in the 
elution time can be attributed due to the interaction of the peptides and protein with the 
gold nanoparticles.  Despite the interaction with the nanoparticles, there is no clear 
separation between Aβ40 and Aβ42.  This could be due to the fact that the dye molecule is 
rather large (1000 Da), which might negate the small difference in the peptides’ mass to 
charge ratios and the slight differences in their polarities.   
 
 
Figure 25. Electropherogram of Tau, AB40, AB42, and mix (DyLight™) with 
functionalized nanoparticles 
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Figure 26 Figure 28 shows a comparison of the electropherograms of 100 nM Aβ40 
with and without nanoparticles.  The bottom blue trace shows the electropherogram of 
Aβ40 in the analysis that did not contain nanoparticles in the run buffer.  The peptide is 
shown eluting at approximately 5 minutes with the free dye around 6.75 minutes.  The 
top red trace shows the electropherogram of Aβ40 in the analysis that had nanoparticles in 
the run buffer.  The peptide’s retention time was shifted to approximately 8.5 minutes. 
 
 
Figure 26. Electropherogram of AB40 (DyLight™) with/without functionalized 
nanoparticles 
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Figure 27 shows the comparison in the electropherograms of Aβ42 both with and 
without nanoparticles to demonstrate the effect that the nanoparticles have on the 
retention time of the peptide.  The bottom blue trace shows 100 nM Aβ42 in the analysis 
that did not have the functionalized nanoparticles in the run buffer.  The peptide is shown 
eluting after 5 minutes with the free dye eluting at 6.75 minutes.  The top red trace shows 
Aβ40 in the analysis that did contain the nanoparticles in the run buffer demonstrating a 
shift in the elution time of the peptide to 8.5 minutes and the free dye to about 14 
minutes. 
 
 
Figure 27. Electropherogram of AB42 (DyLight™) with/without functionalized 
nanoparticles 
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Figure 28 shows the electropherograms for 10 nM tau both with and without 
nanoparticles.  The bottom blue trace shows the analysis of tau that did not contain the 
nanoparticle pseudostationary phase.  The protein is eluting after approximately 6 
minutes.  The top red trace shows the electropherogram of 10 nM tau protein in the CE 
analysis that did contain functionalized nanoparticles.  The nanoparticles were shown to 
shift the elution time of the protein from 6 minutes to almost 11 minutes. 
 
 
Figure 28. Electropherogram of Tau (DyLight™) with/without functionalized 
nanoparticles 
 
 
 
 
Despite displaying a delayed retention time in the presence of the functionalized 
gold nanoparticles, there was not enough interaction with the particles to separate the 
amyloid beta peptides.  Because of this the pH and the applied voltage were both 
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decreased to increase the amount of time the analytes would spend in the capillary.  At 
the lower pH there is a higher ratio of silanols that are protonated which decreases the 
bulk flow.  The decrease in the voltage also decreases the electroosmotic flow because 
they are directly proportional.  This decrease in the electroosmotic flow thereby increases 
the elution times of the analytes.  In other words the analyte would have more time to 
interact with the nanoparticles.  Even under these conditions, separation of the amyloid 
beta peptides was not achieved.  It was believed that the size of the DyLightTM dye was 
the main reason for this.  The DyLightTM dye adds approximately 1000 Da with each 
attachment.  Since the peptides are only 4328 Da (Aβ40) and 4514 Da (Aβ42), the addition 
of such a large mass would decrease the difference in their charge to size ratios and 
decrease the differences in their polarity.  The peptides were then derivatized with the 
smaller ATTO-TAGTM FQ and run at the lower pH with lower applied voltage.  The new 
buffer that was used was a 40 mM MES buffer at pH 5.00.  This buffer was also used to 
suspend the nanoparticles to act as a pseudo stationary phase.  The results of this analysis 
were somewhat surprising.  Shown in Figure 29 is the electropherograms of 1 µM 
amyloid beta 40 (bottom blue trace), 1 µM amyloid beta 42 (second from bottom red 
trace), and 10 nM tau (top green trace), and a mixture of each of the biomarkers shown in 
the trace second from the top (pink trace).  The analysis at lower pH appears to have 
allowed separation of the amyloid beta peptides without requiring the nanoparticle 
pseudostationary phase.  Amyloid beta 40 is being shown to elute at around ten minutes.  
The slightly larger amyloid beta 42 eluted at 7.5 minutes.  The tau protein is eluting at 
close to 16 minutes.  While the separation under these conditions is surprising, the elution 
69 
 
order can be rationalized.  At this pH the peptides are traveling as anions and are eluting 
after the electroosmotic flow.  This fact was confirmed by determining the retention time 
of pure DMSO which acts as an electroosmotic flow marker.  The peptides were shown 
to be eluting after this marker signifying that they are traveling as anions.  Analytes with 
the same charge will then be separated by their mass.  In this case since the amyloid beta 
40 is smaller than amyloid beta 42 it has a greater electrophoretic mobility towards the 
inlet and therefore spends more time in the capillary.  The tau protein is eluting last due 
to its greater mass. 
 
 
Figure 29. Electropherogram of Alzheimer's Disease Biomarkers at pH 5 
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 Despite being able to separate the biomakers in a buffer not containing 
nanoparticles, the analysis with nanoparticles was still performed.  The conditions were 
identical to those of the previous analysis only the run buffer contained the functionalized 
gold nanoparticles.  Figure 30 shows the results of this analysis.  The blue trace on the 
bottom is 10 µM amyloid beta 40.  It is being shown eluting at 16.8 minutes.  The next 
trace up in red is 10 µM amyloid beta 42.  This peptide elutes earlier at 11.3 minutes.  
Shown on top in green is the electropherogram of the 10 nM tau eluting after 24 minutes. 
The trace in purple shows the mixture of 10 µM amyloid beta 40, 10 µM amyloid beta 42 
and 10 nM tau in a single analysis with each of the biomarkers’ elution times 
corresponding to the individual analyses.  It is important to note that there is an increase 
in the resolution of the biomarkers where the amyloid betas are separated by 5.25 minutes 
and the peptides are separated from the tau protein by approximately 7.25 minutes.   
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Figure 30. Electropherogram of Alzheimer's Disease Biomarkers at pH 5 with 
functionalized gold nanoparticles 
 
 
 
 
Conclusion 
 The use of the functionalized gold nanoparticle pseudostationary phase in a 
capillary electrophoretic analysis of Alzheimer’s Disease biomarkers has enhanced the 
separation of the peptides allowing for quantitation.  The initial dye that was used 
(DyLightTM) negated the slight difference in mass and polarity of the difficult to separate 
amyloid beta peptides.  By using a smaller dye and slowing the electroosmotic flow by 
decreasing the pH of the run buffer and lowering the potential across the capillary, the 
separation of the amyloid beta peptides was achieved.  The separation of the biomarkers 
allows for quantitation to be conducted.  This implies that this type of analysis could be 
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conducted to determine the relative concentrations of the amyloid beta peptides and the 
tau protein in a single analysis that would take approximately 2.5 hours including time 
for the fluorescent derivatization of the biomarkers.  
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CHAPTER VII 
 
CONCLUSION AND FUTURE WORK 
 
 
Conclusion 
 This study achieved the synthesis and characterization of the asymmetric 
disulfide, 10-(dodecyldisulfanyl) decane-1-sulfonic acid.  The disulfide was characterized 
through FTIR , ESI-MS, and NMR.  This disulfide was then chemisorbed onto the 
surface of 10 nm gold nanoparticles.  The conditions for this derivatization were then 
optimized for the concentration of the disulfide and reaction time of derivatization.  Each 
Alzheimer’s Disease biomarker was then derivatized with a fluorescent dye so that they 
could be detected in a capillary electrophoretic analysis using laser-induced fluorescence 
detection.  The pH of the fluorescent derivatization of the amyloid beta peptides was then 
optimized to give the highest monodispersity in the molecular weights when analyzed by 
MALDI-TOF MS.  The fluorescently derivatized biomarkers were then analyzed by 
capillary electrophoresis both with and without the functionalized gold nanoparticle 
pseudostationary phase.  The separation of the biomarkers was achieved at pH 5 at 10 kV 
even without the presence of the nanoparticles.  The analysis with the nanoparticles 
exhibited increased separation between the amyloid beta peptides and the tau protein.   
The resolution of Aβ40 and Aβ 42 was increased by 2.6 minutes, Aβ42 and tau was 
increased by 4.6 minutes, and Aβ40 and tau was increased by 2.0 minutes.  This 
increased resolution would make future method development easier even in the presence 
of interfering species.  Both analyses with and without nanoparticles were completed 
within 90 minutes including fluorescent derivatization of the biomarkers and the analysis 
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time.  This technique provides a fast multianalyte analysis of the biomarkers in clean 
media.  What still remains is the analysis of these biomarkers in cerebrospinal fluid, 
however, the high efficiency of capillary electrophoresis should be able to resolve these 
biomarkers from interfering species present in the sample matrix.   
Significance 
 Currently the only definitive diagnosis for Alzheimer’s Disease is through an 
autopsy to verify the presence of amyloid plaques and neurofibrillary tangles in the 
patient’s brain.  Diagnosis of the disease involves ruling out the other forms of dementia 
first then relying on tests of cognitive function and memory to determine if AD is the 
cause.  Also currently assisting in the diagnosis, is the use of Magnetic Resonance 
Imaging (MRI) to provide evidence for brain atrophy due to neuronal loss.53  It has been 
shown that the relative concentrations of biomarkers such as Aβ1-40, Aβ1-42, 
phosphorylated Tau (at threonine 181), and total Tau can be very useful in giving a more 
accurate diagnosis.  The only test that is utilized to determine the concentrations of these 
biomarkers is ELISA.  Analysis by ELISA is very time consuming and expensive 
because each biomarker would require a separate analysis.  The results of ELISA tests 
have been shown to be widely variable.54  Probably one of the biggest drawbacks to an 
ELISA analysis is the problem of accuracy.  These are known to be inaccurate at 
correctly determining analyte concentrations.  A CE analysis could invoke the use of an 
internal standard to help verify the relative concentrations.  This study proposed the use 
of capillary electrophoresis for the separation of these biomarkers.  CE experiments are 
often very fast (around 10 minutes) and consume very little sample (~3-5 nL).  The 
knowledge of the relative concentrations of the biomarkers could lead to a faster and 
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more accurate diagnosis of the disease.  It would also provide a means of tracking 
progression of the disease to determine the efficacy of various treatments.  
Future Work 
 From here this analysis can provide information that is imperative to diagnosing 
Alzheimer’s disease.  Work should be done to decrease the detection limits of the 
biomarkers so that biologically relevant concentrations of the biomarkers can be detected.  
Future studies should also include the quantitation of the phosphorylated form of the tau 
protein to provide a complete description of the disease progression. 
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